Clinical Trials Browser

Breast Neoplasms

NCT00601900 2025-05-23

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Phase 3 Completed

394 enrolled 11 charts

Breast

Breast Neoplasms

NCT00520975 2025-03-28

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Phase 3 Terminated

96 enrolled 16 charts

Breast

Breast Neoplasms

NCT00028990 2023-06-15

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 3 Completed

722 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00545077 2023-03-31

Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women

Phase 3 Completed

380 enrolled 21 charts

Breast

Breast Neoplasms

NCT03462251 2023-01-19

RIBBIT

Phase 3 Completed

41 enrolled

Breast

Breast Neoplasms

NCT00785291 2022-10-10

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Phase 3 Completed

799 enrolled 18 charts

Breast

Breast Neoplasms

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase 3 Completed

1,613 enrolled

Breast

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT00625898 2020-09-10

BETH

Phase 3 Terminated

3,509 enrolled

Breast

Breast Neoplasms

NCT01935492 2020-01-18

Stop&Go

Phase 3 Completed

420 enrolled

Breast

Breast Neoplasms

NCT00600340 2019-12-30

TURANDOT

Phase 3 Completed

564 enrolled 72 charts

Breast

Breast Neoplasms

NCT01131195 2019-05-15

Metronomic Therapy in Metastatic Breast Cancer.

Phase 3 Completed

139 enrolled

Breast

Breast Neoplasms

NCT01663727 2019-01-22

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

Phase 3 Completed

481 enrolled 22 charts

Breast

Breast Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast

Breast Neoplasms

NCT00868634 2016-08-31

CARIN

Phase 3 Completed

600 enrolled

Breast

Breast Neoplasms

NCT01250379 2016-02-11

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

Phase 3 Completed

494 enrolled 30 charts

Breast

Breast Neoplasms

NCT00567554 2016-02-10

GeparQuinto

Phase 3 Completed

2,600 enrolled

Breast

Breast Neoplasms

NCT00333775 2016-01-27

A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

Phase 3 Completed

736 enrolled 12 charts

Breast

Breast Neoplasms

NCT00528567 2015-09-04

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

Phase 3 Completed

2,591 enrolled 15 charts

Breast

Breast Neoplasms

NCT00391092 2015-08-28

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Phase 3 Completed

424 enrolled 12 charts

Breast

Breast Neoplasms

NCT00448591 2015-05-25

A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.

Phase 3 Completed

2,296 enrolled 11 charts

Breast

Breast Neoplasms

NCT00929240 2015-03-03

A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Phase 3 Completed

287 enrolled 18 charts

Breast

Breast Neoplasms

NCT00109239 2014-06-18

A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer

Phase 3 Completed

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00096967 2014-03-26

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Phase 3 Completed

100 enrolled

BreastGastrointestinal

Breast Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00262067 2013-12-13

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Phase 3 Unknown

1,237 enrolled 14 charts

Breast

Breast Neoplasms

NCT00281697 2013-07-26

A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)

Phase 3 Completed

684 enrolled 12 charts

Breast

Breast Neoplasms

NCT01200212 2013-05-22

TABEA

Phase 3 Terminated

432 enrolled

Breast

Breast Neoplasms

NCT00373256 2012-09-10

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Phase 3 Completed

488 enrolled 12 charts

Breast

Breast Neoplasms

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Phase 3 Unknown

800 enrolled

Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Clinical Trials

AMBITION

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women

RIBBIT

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

BETH

Stop&Go

TURANDOT

Metronomic Therapy in Metastatic Breast Cancer.

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

CARIN

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

GeparQuinto

A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.

A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)

TABEA

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer